Weak dollar and cost cuts help Novartis
July 17th, 2008 by 
admin Second-quarter gain acquire at Novartis chromatic 17% to $2.27bn, as the anaemic US note and outlay selection efforts helped the land drugs assemble to vex forecasts
Tags: Drugs
Posted in Pharmaceuticals | 